Abstract: The panoramic-reconstruction temporal imaging (PARTI) system is a single-shot optical waveform measurement apparatus that achieves scalable record length and sub-picosecond resolution simultaneously for ultrafast non-repetitive waveform characterization, in analogy with the wisdom of stitching multiple mosaic images to achieve larger-field-of-view in the spatial domain. It consists of a high-fidelity optical buffer, a low-aberration time magnifier and synchronization-control electronics. For specific measurement circumstances, the PARTI system can also be carried out based on a passive optical buffer, which reduces the system complexity. The PARTI system is configured for real-time single-shot characterization of non-repetitive optical dynamic waveform that evolves over a time scale much larger than that of its ultrafast temporal details, i.e., optical dynamics with large time-bandwidth product.

Abstract: It is directed towards methods and systems for omni-directional wireless power transfer. The method comprises generating magnetic field in all directions, detecting the loads based on the magnetic field shape and focusing the power flow towards the detected loads, so as to maximize the energy efficiency of the wireless power transfer.

Abstract: The present invention pertains to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and (E)-3-(3,4-dihydroxyphenyl)-N-(prop-2-yn-1-yl)acrylamide of Formula (I): The invention also pertains to a method for stimulating neurite outgrowth by administering to cells in the area where neurite outgrowth is desired a therapeutically effective amount of the compound of Formula (I). Further, the invention pertains to a method for attenuating neuron injury in a subject by contacting a neuron in a subject in need thereof with a therapeutically effective amount of the compound of Formula (I). Furthermore, a method of preparing the compound of Formula (I) are provided.

Abstract: The present invention provides a wireless power transmitter comprising at least two loops, and separate drivers, each driving a respective one of the loops and providing a respective alternating current to the respective loop, thereby to transmit wireless power for receipt by at least one wireless power receiver. Also provided is a wireless power receiver comprising a receiver loop, and at least two focusing loops. An associated system and an associated method are also provided.

Abstract: A consumer product elec-tric power supply is provided and includes a grid power converter that is coupled to a power grid; an energy storage element that is coupled to the grid power converter, which provides an intermediate voltage to the energy storage element; a load power converter that is coupled to the energy storage element and provides constant power to a load; and a power controller that measures a state variable of the grid, wherein the power controller controls the grid power converter based on the state variable of the grid to help stabilize the grid.

Abstract: Methods for treating or preventing one or more symptoms of rheumatoid arthritis or other types of inflammatory arthritis involves administering a formulation containing an effective amount of arsenic trioxide to an affected patient. The arsenic trioxide formulation can be administered orally, for example, as a solution, suspension, syrup, emulsion, tablet, or capsule.

Abstract: Described are metal complexes for the selective detection of ascorbic acid or ascorbate. The metal complexes act as molecular sensors, and are useful in detecting ascorbate in live biological samples, commercial samples, or both. The selective ascorbate sensing involves an ascorbate-selective bond cleavage reaction. The bond cleavage is not limited to the construction of molecular sensors, but also includes other stimuli-responsive materials, i.e., materials that adopt a physical state, such as gel formation, upon ascorbate-selective bond cleavage of the metal complexes.

Abstract: The present disclosure relates to the design and generation of stapled helical peptides that perturb protein-protein interactions (PPIs). The methods disclosed herein for preparing stapled peptides involve providing a peptide having a first amino acid that is functionalized with a salicylaldehyde ester side group and a second amino acid functionalized with a 1,2-hydroxyl amine side group; reacting the first and second amino acids to generate an N,O-benzylidene acetal moiety; and performing acidolysis of the resultant N,O-benzylidene acetal moiety to generate the stapled peptide. In many forms, the stapled helical peptides described herein are not hydrophobic.

Abstract: A power converter comprising one or more switch blocks. Each switch block has: a plurality of switch-pairs each having two switches connected in series to each other; a plurality of primary nodes each interconnecting the switches in a respective switch-pair; and a plurality of secondary nodes, each switch-pair being connected in series to an adjacent switch-pair through a said secondary node to form a serial chain of switch-pairs, the secondary nodes including a secondary node at one end of said serial chain and a secondary node at another end of said serial chain. Each adjacent pair of said primary nodes is connectable to a flying capacitor. Each pair of said secondary nodes is connectable to one or more of the following: one or more bypass capacitors, and one or more other said switch blocks.

Abstract: Methods of diagnosis and/or prognosis of malignant disease from pleural effusion samples are disclosed. The methods typically include determining the normalized intensity of one or more biomarkers, such as acetone and 3-hydroxybutyate, in pleural effusion samples using nuclear magnetic resonance (NMR), such as proton NMR (1H-NMR) spectroscopy. Reference values for malignant disease diagnosis using the disclosed biomarkers are provided. Reference values for prognosis of median survival time based on the disclosed biomarkers are also provided.

Abstract: Methods of classifying pleural fluid are disclosed. The methods typically include determining the level of indicator nanoparticles, such as lipids, particularly large lipids, in the pleural fluid of a subject. The level of lipids can be determined by nuclear magnetic resonance (NMR), such as proton NMR (1H-NMR) by measuring the NMR signal corresponding to methyl protons, methylene protons, methene protons, or combinations thereof. The level of large lipids in pleural fluid can be carried out in vitro on a sample of pleural fluid obtained from the subject or in vivo using magnetic resonance spectroscopy (MRS). The pleural fluid can be classified as exudate or transudate with a sensitivity, selectivity, or combination thereof of 85%, 90%, 95%, 99%, or higher, a selectivity of 85%, 90%, 95%, 99%. The method can be coupled with diagnosing and/or treating the subject with a disease, disorder, or condition.

Abstract: Embodiments may pertain to methods for preparing a transition metal oxide.

Abstract: Disclosed are antibodies, or binding fragments thereof, that specifically bind to human HER2 and human IGF-IR. Also provided are nucleic acid molecules encoding the disclosed antibodies and binding fragments and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of HER2 and IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.

Abstract: The present invention provides methods, compositions, and kits wherein nanomaterials are used for inhibiting cancer stem cell division, colony formation, spheroid formation and self-renewal. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for treating cancer, coating tumors, and inhibiting metastasis. The present invention also provides methods, compositions, and kits wherein nanomaterials are used for inducing cells to go into stasis. The present invention further provides methods for isolating tumors, inhibiting bleeding, and marking margins of tumors and organs during surgery with a nanomaterial.

Abstract: The subject invention pertains to medical apparatuses and methods for reducing or preventing leakage of injected therapeutic agents (including liquid-containing substances, cells) into a solid or hollow tissue/organ after puncturing.

Abstract: A novel class of saturated or conjugated dendrimers containing at least one strong ?-donating group coordinated to cyclometalated tridentate gold(III) compounds having the chemical structure depicted by generic formula: wherein: (a) [Au] is a cyclometalated tridentate gold(III) group; (b) Unit A is a ?-donating chemical group; (c) Unit B is a central part of the dendrons comprising a branch point of component dendrimers; (d) Unit C is optional surface groups or dendrons of the dendrimers; (e) n=0 or 1.

Abstract: Disclosed is a membrane surface modification method. The method is applicable to a variety of hydrophobic membranes by doping selected inorganic particles. One act of the method involves the in-situ embedment of the inorganic particles onto the membrane surface by dispersing the particles in a non-solvent bath for polymer precipitation. Further membrane surface modification can be achieved by hydrothermally growing new inorganic phase on the embedded particles. The embedment of particles is for the subsequent phase growth.

Abstract: Compositions and methods for diagnosing, treating and/or preventing cancers characterized by CDH17 overexpression based on the detection of CDH17 or the use of CDH17 as a target for therapeutic intervention or prophylactic intervention are provided. Methods for diagnosing and/or monitoring liver cancers using the expressing of CDH17 involve detecting and/or quantitating the CDH17 protein or encoding nucleic acids (DNA or RNA) in a biological sample such as urine from the subject. Methods for treating liver cancers using CDH17 as a target and of sensitizing cells with aberrant expression of CDH17 have also been developed. The methods include suppression or knockdown of the expression of CDH17 by administering an effective amount of a CDH17 inhibitor.

Abstract: A one-step method for fabricating solidified particles from all-aqueous emulsion droplets involves solidification and drying of the droplets by osmosis. According to this method the fabrication of solidified particles is induced by implementing a high osmotic pressure gradient between the internal phase and external phase of the all-aqueous emulsion. The resultant extraction of water leads to solidification of the emulsion droplets. This approach provides mild conditions for encapsulating bioactive ingredients or other delicate components to conveniently fabricate bio- and cyto-compatible particles because it does not involve the introduction of external energy used in conventional drying. Such conventional external energy inputs are time-consuming, so the method is more efficient.